Children's medicines

In partnership with organisations representing health professionals, children and young people, parents and carers, the College manages and supports projects in medicines for infants, children and young people. 

• Latest news - Medicines for Children launches new website
• Joint RCPCH/NPPG standing committee on medicines
• Unlicensed medicines statement
• Medicines for Children Research Network

The Medicines Committee is a unique collaborative standing committee with membership split between the RCPCH and Neonatal and Paediatric Pharmacists Group (NPPG).

The Committee has five key work areas:

1. Responding to consultation documents in government health policy and clinical guidelines, standards and appraisals of medicines

2. Inputting into strategic and policy issues on the British National Formulary for Children (BNF-C) and supporting its production

3. Responsibility for the production of medicines information for parents and carers

4. Advising and supporting RCPCH and NPPG on lobbying Government and other agencies on policy issues on licensing, availability and use of medicines in children

5. Working with the Medicines for Children Research Network in relation to research opportunities and practice implications

For more information about the Committee, email the Committee Administrator.

The Medicines Committees works with the MCRN, which was developed in 2005 to improve the coordination, speed and quality of randomised controlled trials and other well-designed studies of medicines for children and young people. It is one of six research networks managed by the UK Clinical Research Network (UKCRN).

For more information, visit the MCRN website.